The Antimicrobial/Elastase Inhibitor Elafin Regulates Lung Dendritic Cells and Adaptive Immunity
- 1 May 2006
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 34 (5) , 634-642
Abstract
Infections with bacteria and viruses such as adenovirus are a feature of chronic lung diseases such as chronic obstructive pulmonary diseases (COPD), and may be instrumental in the generation of disease exacerbations. We have previously shown in acute models that elafin (a lung natural chemotactic molecule for macrophages and neutrophils, with potent antimicrobial and neutrophil elastase inhibitor activity) is upregulated in infection and modulates innate immunity. Here we present data using two independent systems of elafin overexpression in vivo (recombinant adenovirus [Ad-elafin] and an elafin transgenic mouse line) to examine the function of elafin in adaptive immunity. We show that elafin increases the number (immunofluorescence) and activation status (flow cytometric measurement) of CD11c+/MHCII+ lung dendritic cells in vivo. Analysis of cytokines produced by spleen and lung cells, and of antibodies measured in serum and bronchoalveolar lavage fluid, shows that the immunity induced is biased toward a type 1 response (production of IL-12, IFN-γ, and IgG2a). Furthermore, elafin overexpression protected mice against further challenge with Ad-LacZ, as assessed by antibody levels and neutralization titer, as well as LacZ expression in lung tissue. Thus, the pleiotropic molecule elafin has significant potential in modulating antigen-presenting cell numbers and activity, and could be beneficial in mucosal protective strategies.Keywords
This publication has 42 references indexed in Scilit:
- SLPI and elafin: one glove, many fingersClinical Science, 2005
- Anti-endotoxin properties of cationic host defence peptides and proteinsInnate Immunity, 2005
- Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface‐enhanced laser desorption/ionization‐mass spectrometry profiling with mass spectrometric protein identificationProteomics, 2005
- Antimicrobial Peptides: Mediators of Innate Immunity as Templates for the Development of Novel Anti-Infective and Immune TherapeuticsCurrent Pharmaceutical Design, 2004
- Dendritic CellsAnnals of the New York Academy of Sciences, 2003
- Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2Science, 2002
- Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbationsThorax, 2002
- Genetic Variants of Human β-Defensin-1 and Chronic Obstructive Pulmonary DiseaseBiochemical and Biophysical Research Communications, 2002
- Role of Latent Viral Infections in Chronic Obstructive Pulmonary Disease and AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6Science, 1999